Guidelines for Stability Testing of Active Pharmaceutical Ingredients (APIs) as per ICH Q7A
1) Purpose
The purpose of this Standard Operating Procedure (SOP) is to outline the procedure for conducting stability testing of Active Pharmaceutical Ingredients (APIs) in accordance with the ICH Q7A guidelines. This SOP ensures that the stability data generated supports the quality, safety, and efficacy of APIs throughout their intended shelf life.
2) Scope
This SOP applies to all personnel involved in the design, execution, and documentation of stability studies for APIs intended for global markets.
3) Responsibilities
Stability Testing Team: Responsible for conducting stability studies and documenting results in compliance with ICH Q7A guidelines.
Quality Assurance (QA) Team: Responsible for reviewing and approving stability study protocols and reports.
Regulatory Affairs Team: Responsible for ensuring that stability studies meet the regulatory expectations of target markets.
4) Procedure
4.1 Preparation for Stability Testing
4.1.1 Obtain and
review the latest version of the ICH Q7A guidelines for stability testing of APIs.4.1.2 Develop a stability protocol that includes study design, testing schedule, storage conditions, and testing parameters as per ICH Q7A guidelines.
4.2 Selection of Batches and Samples
4.2.1 Select representative batches of the API, typically three primary batches manufactured using the
4.2.2 Prepare sufficient samples to cover the entire study duration, considering the number of time points and tests to be conducted.
4.3 Defining Storage Conditions and Time Points
4.3.1 Define the storage conditions according to ICH Q7A guidelines, typically including:
- Long-term stability: 25°C ± 2°C/60% RH ± 5% RH
- Accelerated stability: 40°C ± 2°C/75% RH ± 5% RH
4.3.2 Establish the time points for sampling, such as 0, 3, 6, 9, 12, 18, and 24 months for long-term studies, and additional time points for accelerated studies.
4.4 Conducting Stability Tests
4.4.1 Store samples under the defined conditions, monitoring temperature and humidity to ensure compliance with the set parameters.
4.4.2 At each specified time point, remove samples and conduct stability-indicating tests, including physical, chemical, microbiological, and functional tests, as applicable.
4.4.3 Record all results meticulously in stability data sheets, ensuring accuracy and traceability of data.
5) Abbreviations, if any
API: Active Pharmaceutical Ingredient
ICH: International Council for Harmonisation
QA: Quality Assurance
RH: Relative Humidity
6) Documents, if any
Stability protocol, stability data sheets, stability testing records, stability report, submission package to regulatory authorities.
7) Reference, if any
ICH Q7A: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.
8) SOP Version
Version 1.0

